Baudax Bio, Inc. is a biotechnology company based in Malvern, PA, dedicated to developing and commercializing innovative products for rare and autoimmune diseases. With a commitment to providing meaningful therapeutic options, their pipeline includes clinical and early-stage product candidates, including the recently acquired TCR TReg platform and two novel neuromuscular blocking agents and a related proprietary chemical reversal agent.
Driven by a mission to bring hope to patients, healthcare providers, and payers, Baudax Bio focuses on addressing unmet medical needs in the field of rare and autoimmune diseases. Through their innovative portfolio pipeline, they aim to make a significant impact in improving the lives of those affected by these conditions.
Generated from the website